Dear Editor,
The diagnostic approach for ventilator-associated pneumonia (VAP) needs to be improved [1]. Volatile organic compounds (VOCs), produced either by invading respiratory pathogens or the patient’s pulmonary defense system, could serve as early diagnostic markers for VAP [2]. Electronic nose (eNose) technology integratively captures complex VOC mixtures to create a ‘VOC fingerprint’ using an array of semi-selective sensors [3]. We hypothesized that an eNose would be able to discriminate patients with VAP from those without VAP based on analysis of headspace air from tracheal aspirates (TAs).
In a prospective cohort study we collected TAs every third day from 45 intensive care unit (ICU) patients who were ventilated for more than 7 days. Fourteen patients developed VAP, 14 patients had airway colonization but did not develop VAP and 17 patients developed neither VAP nor airway colonization (study methodology and patient characteristics are given in the Electronic Supplementary Material). The eNose was able to accurately discriminate patients with VAP from those without VAP in both a cross-sectional and longitudinal analysis (Fig. 1, upper panels), and the use of a ‘VOC fingerprint’ was found to improve the diagnostic accuracy of the Clinical Pulmonary Infection Score (Fig. 1, lower panels) in this small cohort of patients. Notably, discrimination by the eNose was not affected by airway colonization, and the findings were independent of the number of colony forming units in the TAs.
Our study has several limitations. First, we were not able to identify which VOCs differentiate between patients with VAP and those without VAP. Furthermore, this study was performed in a highly selected cohort of patients, and the sample size was rather small, thereby limiting generalization of our findings. Indeed, the results of our study need to be confirmed in robust and larger studies.
Of interest, the results of our study suggest that the observed changes in VOC-fingerprints are not solely the result of the presence or absence of bacteria in TAs. VOC-fingerprints can change with the bacterial ecology from colonization to infection, which is known to modulate bacterial metabolism [4]. In addition, host responses may have an effect on VOC mixtures [5].
Taken together, these results suggest that volatile biomarkers may be complementary to clinical disease markers for the diagnosis of VAP. However, the exact role of eNose technology in clinical practice with respect to VAP diagnosis is as yet far from certain. One next step could be to determine which VOCs have the highest discriminative power, such as by using gas chromatography and mass spectrometry to customize eNose sensor arrays. Studies using relevant outcome measures are also needed that compare diagnostic strategies which include and do not include VOC analysis.
References
Fàbregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, de la Bellacasa JP, Bauer T, Cabello H (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867–873
Bos LDJ, Sterk PJ, Schultz MJ (2013) Volatile metabolites of pathogens: a systematic review. PLoS Pathog 9:e1003311
Röck F, Barsan N, Weimar U (2008) Electronic nose: current status and future trends. Chem Rev 108:705–725
Whiteson KL, Meinardi S, Lim YW, Schmieder R, Maughan H, Quinn R, Blake, Conrad D, Rohwer F (2014) Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation. ISME J. doi:10.1038/ismej.2013.229
Aksenov AA, Gojova A, Zhao W, Morgan JT, Sankaran S, Sandrock CE, Davis CE (2012) Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell’s “chemical odor fingerprint”. ChemBioChem 13:1053–1059
Acknowledgments
The authors acknowledge Centro de Investigación Biomédica en Red-Enfermedades Respiratorias (CibeRes)–Instituto de Salud Carlos III (ISCIII) (ISCIII/FIS-PI 12/01815) for financial support. The project was co-sponsored by a research grant from Insitut Mérieux, Lyon, France (2011). LDJB is supported by an unrestricted research grant from Philips Medical research, a research grant (PhD Scholarship) of the Academic Medical Center, Amsterdam, the Netherlands (http://www.amc.nl/ web/Onderwijs/PhD/AMC-Scholarships/AMC-Scholarschip-winners.htm) and by the ESICM Young Investigator Award (http://www.esicm.org/research/eccrn/awards-winners).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bos, L.D.J., Martin-Loeches, I., Kastelijn, J.B. et al. The volatile metabolic fingerprint of ventilator-associated pneumonia. Intensive Care Med 40, 761–762 (2014). https://doi.org/10.1007/s00134-014-3260-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-014-3260-5